Omega Fund Management, LLC - REPLIMUNE GROUP INC ownership

REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 100 filers reported holding REPLIMUNE GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of REPLIMUNE GROUP INC
ValueSharesWeighting
Q3 2023$51,352,568
-26.3%
3,001,3190.0%47.17%
+20.8%
Q2 2023$69,690,627
+29.4%
3,001,319
-1.6%
39.05%
+11.1%
Q1 2023$53,866,302
-41.1%
3,050,187
-9.3%
35.13%
+14.0%
Q4 2022$91,441,123
+23.5%
3,361,806
-21.6%
30.82%
+13.6%
Q3 2022$74,056,000
-9.3%
4,288,154
-8.2%
27.12%
+4.0%
Q2 2022$81,691,000
+2.9%
4,673,3800.0%26.08%
+60.6%
Q1 2022$79,354,000
-38.5%
4,673,380
-1.9%
16.24%
-11.0%
Q4 2021$129,088,000
-11.0%
4,763,380
-2.7%
18.25%
+12.1%
Q3 2021$145,120,000
-24.6%
4,896,074
-2.2%
16.28%
-25.2%
Q2 2021$192,417,000
+25.9%
5,008,2450.0%21.78%
+50.7%
Q1 2021$152,802,000
-21.1%
5,008,245
-1.3%
14.45%
-50.2%
Q4 2020$193,603,000
+58.2%
5,074,783
-5.1%
29.03%
-12.3%
Q3 2020$122,395,000
-7.4%
5,344,9710.0%33.11%
-8.4%
Q2 2020$132,161,000
+150.2%
5,344,971
+0.4%
36.14%
+65.3%
Q1 2020$52,825,000
-30.6%
5,323,4550.0%21.86%
-9.8%
Q4 2019$76,142,000
+7.7%
5,323,455
+4.3%
24.24%
+11.1%
Q3 2019$70,688,000
-5.2%
5,103,4550.0%21.82%
+14.7%
Q2 2019$74,567,000
-51.8%
5,103,455
-50.0%
19.02%
-41.9%
Q1 2019$154,850,000
+203.4%
10,206,910
+100.0%
32.73%
-13.5%
Q4 2018$51,035,000
-37.9%
5,103,4550.0%37.84%
-2.7%
Q3 2018$82,166,0005,103,45538.87%
Other shareholders
REPLIMUNE GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,050,187$53,866,30235.13%
Atlas Venture Life Science Advisors, LLC 2,098,300$37,055,9785.02%
Redmile Group, LLC 3,811,988$67,319,7082.92%
Nan Fung Group Holdings Ltd 189,339$3,343,7272.28%
Altium Capital Management LP 148,000$2,613,6801.45%
Integral Health Asset Management, LLC 395,000$6,975,7001.40%
BVF INC/IL 2,143,036$37,846,0161.38%
Resolute Capital Asset Partners LLC 82,500$1,4571.06%
SECTORAL ASSET MANAGEMENT INC 262,200$4,630,4520.89%
Frazier Life Sciences Management, L.P. 686,762$12,128,2170.88%
View complete list of REPLIMUNE GROUP INC shareholders